Contractor
NOVARTIS PHARMACEUTICALS CORPORATION
- UEI
- NG61ZA8TADW3
- Resolved by
- uei
- Confidence
- 1.000
Active from Jul 30, 2020 to Sep 17, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36C26226F0048 PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML) | Department of Veterans Affairs | AZ | Dec 30, 2025 | $1,646,124 |
| 36C26226N0112 PLUVICTO AND LUTATHERA | Department of Veterans Affairs | NJ | Oct 8, 2025 | $4,299,447 |
| 36C24125F0148 PLUVICTO | Department of Veterans Affairs | CT | Sep 19, 2025 | $810,281 |
| 36C25026A0001 PLUVICTO | Department of Veterans Affairs | — | Oct 1, 2025 | — |
| 36F79720D0180 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Jul 30, 2020 | — |
| 36C25225N0482 LUTATHERA - LUTETIUM LU 177 DOTATATE | Department of Veterans Affairs | NJ | Aug 7, 2025 | $169,296 |
| 36E79726A0001 BPA FOR KYMRIAH, FABHALTA, NETSPOT, AND LOCAMETZ | Department of Veterans Affairs | — | Oct 1, 2025 | — |
| 36C25526N0394 PLUVICTO SUPPLIES | Department of Veterans Affairs | MO | Aug 24, 2026 | $891,651 |
| 36C25225F0191 DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO. | Department of Veterans Affairs | NJ | Aug 27, 2025 | $1,733,030 |
| 36C25026F0204 PLUVICTO 2026 CLEVELAND | Department of Veterans Affairs | NJ | Jan 5, 2026 | $501,670 |
| 36C25226N0246 PLUVICTO | Department of Veterans Affairs | NJ | Jan 29, 2026 | $823,062 |
| 36C26226F0314 PLUVICTO DELIVERY ORDER | Department of Veterans Affairs | CA | Jul 17, 2026 | $823,062 |
| HHSO100201700026C THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE CANCELLING FUNDS IN THE AMOUNT OF $2,539,496.23 AS FOLLOWS: 1. $1,050,656.17 FROM CLIN 0013 2. $1,488,840.00 FROM CLIN 0014 3. $0.06 FROM CLIN 0012 | Department of Health and Human Services | NJ | Jul 8, 2026 | $16,334,775 |
| 15B41426F00000252 FY26 B1 BIOLOGICS MCK B126495OPM FABHALTA JUL 26 EO 143398 | Department of Justice | NC | Jun 17, 2026 | $0 |
| 15B41426F00000249 FY26 B1 BIOLOGICS MCK B126495OPM FABHALTA JUN 26 | Department of Justice | NC | Jun 17, 2026 | $43,520 |
| 36C24526N0622 FABHALTA 200 MG | Department of Veterans Affairs | NC | Jun 16, 2026 | $34,874 |
| 36C25026N0416 26AP2812 - PLUVICTO - CLEVELAND VAMC | Department of Veterans Affairs | NJ | May 14, 2026 | $617,297 |
| 36C24526N0566 PATIENT MEDICATION OF FABHALTA 200MG TABLETS - ORDER FOR PATIENT AT THE BALTIMORE VA MEDICAL CENTER. | Department of Veterans Affairs | NC | May 4, 2026 | $34,874 |
| 36C25725N0376 PLUVICTO - QUANTITY DECREASE | Department of Veterans Affairs | NJ | Apr 16, 2026 | $857,357 |
| 36C25725N0190 LUTATHERA & PLUVICTO - DE-OBLIGATE EXCESS FUNDS | Department of Veterans Affairs | NJ | Mar 24, 2026 | $2,669,629 |
| 36C24526N0473 FABHALTA 200 MG | Department of Veterans Affairs | NC | Apr 7, 2026 | $34,874 |
| 36C26126F0168 PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML | Department of Veterans Affairs | CA | Mar 27, 2026 | $1,028,828 |
| 36C24526N0385 FABHALTA 200 MG | Department of Veterans Affairs | NC | Mar 6, 2026 | $34,874 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier NG61ZA8TADW3, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 24, 2026.